USPTO serial 77238363
MENISCOCELECT
Reviewed by CopyMark Law Group
Reg. 3662384Status 710
- Filing date
- Status date
- Registration date
- Aug 4, 2009
- Examiner
- EULIN, INGRID C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with MENISCOCELECT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Thomas J. Moore
THOMAS J. MOORE BACON & THOMAS, PLLC625 SLATERS LN FL 4ALEXANDRIA, VA 22314-1169UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Enzymes for scientific research and development in the medical field; antibodies for medical laboratory use, for the purpose of expansion, selection, quality control and implantation of human, in vivo, cartilage forming cells including stem cell preparations of stem cell implants; quality control kits consisting primarily of monoclonal antibodies for use in disease testing and ligands or oligonucleotide primers and DNA chips for scientific or research use; quality control kits consisting primarily of antibodies or oligonucleotide primers and DNA chips for selection and quality control of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants for research/scientific use | SECTION 8 - CANCELLED | — |
| 005 | Antibodies for medical diagnostic use, for the purpose of expansion, selection, quality control and implantation of human, in vivo, cartilage forming cells including stem cell preparations of stem cell implants; pharmaceutical, veterinary or medical preparations for expansion, selection, quality control and implantation of human, in vivo, cartilage forming cells; nutritious media and growth substrates for expansion, selection, quality control and implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants; medical preparations, namely, polymer preparations and cell matrices of any type of origin for expansion, selection, medical quality control and implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants; test products for medical use, for the purpose of the control of expansion, selection, and implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants, namely, chondrocytes, chondrocyte progenitors, chondrocyte precursors and stem cells with chondrogenic properties; hormones for the promoting of the growth of cells called growth factors for medical use; veterinary or medical kits for expansion, selection, quality control and implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants, namely, kits primarily composed of growth and differentiating promoting polypeptides; quality control kits consisting primarily of monoclonal antibodies for use in disease testing and ligands or oligonucleotide primers and DNA chips for medical or veterinary use; quality control kits consisting primarily of antibodies or oligonucleotide primers and DNA chips for selection and quality control of human, in vivo, cartilage forming cells including stem cell preparations and stem cell implants for medical/diagnostic use; implementation kits consisting primarily of live cartilage forming cells | SECTION 8 - CANCELLED | — |
| 010 | Veterinary or medical devices and instruments for expansion, selection, quality control and implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants, namely, kits comprised of temperature probes and injectors, stitching or gluing material for covering implantation devices for human in vivo, cartilage forming cells; medical devices and instrument kits, namely, biopsy instruments, implantation kits including medical syringes, tongs and pliers; quality control kits consisting primarily of DNA chips for medical use including expansion, selection, quality control and implantation of human, in vivo, cartilage forming cells including stem cell preparations and stem cell implants | SECTION 8 - CANCELLED | — |
| 042 | Scientific research, development and study related to expansion, selection, quality control and implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants; quality control for others as related in human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants; custom design, development and performance of biochemical assays for the purpose of quality control of expanded or implanted human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants; scientific research, development and study related to the use of polymer membranes or cell matrices of any type of origin for expansion, selection, quality control and implantation of human, in vivo, cartilage forming cells including stem cell preparations or stem cell implants | SECTION 8 - CANCELLED | — |
| 044 | Pharmaceutical, veterinary or medical services, namely, medical and pharmaceutical consultation and veterinary services | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by TIGENIX N.V.
- Other trademarks owned by TIGENIX N.V.
- Other trademarks owned by TIGENIX N.V.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named MENISCOCELECT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 11, 2016 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jan 23, 2014 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jan 23, 2014 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 4, 2009 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 19, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 29, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Apr 13, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 9, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 9, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 9, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 9, 2009 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 5, 2009 | GPRN | NOTIFICATION OF PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Mar 5, 2009 | GPRA | PRIORITY ACTION E-MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Mar 5, 2009 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Feb 9, 2009 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jan 16, 2009 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jan 8, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 20, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 19, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 19, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 19, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 21, 2008 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 21, 2008 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 21, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 13, 2008 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jun 2, 2008 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| May 22, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 22, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 1, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 1, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 30, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 31, 2007 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 31, 2007 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 31, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 30, 2007 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 25, 2007 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Oct 18, 2007 | ALIE | ASSIGNED TO LIE | — |
| Sep 13, 2007 | PAPER RECEIVED | — | |
| Jul 30, 2007 | NWAP | NEW APPLICATION ENTERED | — |